Thulium Fiber LaserNCT07639385
Fragmentation Vs Dusting With FANS for Renal Stones Less Than 2cm: A Randomized Controlled Study
A study testing Dusting and Fragmentation in people with Thulium Fiber Laser and Fans, run by Bir Hospital.
Trial summary
The use of FANS has changed the operative landscape of RIRS by allowing continuous active suction-assisted clearance of ablated stone material in real time. Use of fragmentation technique in FANS requires high-energy to reduce stone burden into small fragments, followed by active suction of residual fine material. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Thulium Fiber Laser, Fans, Lithotripsy, Laser
- What is being tested?
- Dusting and Fragmentation
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 86 participants
- Where
- No sites listed yet
- Study dates
- 1 Aug 2026to 7 Aug 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥18 years
- Renal stone(s) confirmed on non-contrast CT KUB
- Total stone less than 2cm
- Stone amenable to flexible ureterorenoscopy (FURS)
- FANS advanced beyond Pelvi-Ureteric Junction (PUJ)
- Able and willing to provide written informed consent
- Able to comply with follow-up schedule
Who cannot join
- Active urinary tract infection (positive urine culture) at time of planned surgery
- Anatomical anomalies precluding safe FURS (e.g., infundibular stenosis, severe calyceal diverticulum inaccessible to flexible scope)
- Pregnancy or breastfeeding
- Prior ipsilateral renal surgery within 3 months of enrollment
- Concurrent ureteral stone(s) requiring simultaneous treatment
- Renal anomalies: horseshoe kidney, ectopic kidney
Show all 9Show fewer
- Sheathless procedure
- Unable to comply with follow-up or provide consent
- Participation in another interventional trial within 30 days
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Fragmentation Vs Dusting Using TFL With FANS for Renal Stones Less Than 2cm
The use of FANS has changed the operative landscape of RIRS by allowing continuous active suction-assisted clearance of ablated stone material in real time. Use of fragmentation technique in FANS requires high-energy to reduce stone burden into small fragments, followed by active suction of residual fine material. Dusting with FANS, on the other hand, converts the entire stone volume into sub-millimetre particulate that is continuously suctioned away during lasing potentially offering a more streamlined workflow with potentially less energy usage, reduced mechanical stress on the ureteroscope working channel, and fewer scope withdrawals. The combination of TFL dusting with FANS-assisted real-time evacuation may produce stone-free outcomes equivalent or superior to fragmentation, while offering these additional operative efficiencies.
Whether dusting using TFL with FANS is non-inferior or indeed superior to fragmentation using TFL with FANS in terms of stone-free rate at one month has not been evaluated in prospective randomised trial yet. This study aims to answer that specific question in patients with renal stone less than 2 cm.
Read the detailed description
Urolithiasis is among the most prevalent urological disorders worldwide, with a lifetime recurrence risk ranging from 30 to 50% in affected individuals. Global Burden of Disease study in 2021 estimated 106 million new incident cases of urolithiasis globally, representing a 47% increase from 1990, driven by population growth, changing dietary patterns, rising rates of metabolic syndrome, and climate-related factors. Regions with tropical and subtropical climates including South Asia bear a disproportionately higher burden, with prevalence estimates of 5-10% compared to 1-5% in temperate regions. Nephrolithiasis is not merely a surgical inconvenience; it imposes significant morbidity through recurrent renal colic, obstructive uropathy, urinary tract infection, and progressive renal dysfunction, with substantial associated healthcare costs.
Retrograde Intra-Renal Surgery (RIRS) has become the preferred minimally invasive modality for the definitive management of most renal calculi endorsed by both the European Association of Urology (EAU) and the American Urological Association (AUA) for stones amenable to endoscopic treatment. It offers the advantage of direct pyelocaliceal access without the morbidity of percutaneous access, with established stone-free rates (SFR) exceeding 90% for stones less than 2 cm in contemporary series.
The operative strategy employed during RIRS specifically, the choice between stone fragmentation and stone dusting remains a subject of active clinical debate, with meaningful implications for operative efficiency, stone-free outcomes, and scope longevity. Fragmentation involves delivering high pulse energy (typically 0.8-1.5 J) at low frequency (5-10 Hz) to reduce calculi into retrievable fragments of less than 4 mm. Dusting employs low pulse energy (0.2-0.5 J) at higher frequency (15-25 Hz) to ablate the stone into sub-millimetre powder particles. In the holmium:YAG (Ho:YAG) laser studies, fragmentation consistently demonstrated superior SFRs. El-Nahas et al. reported a significantly higher SFR with fragmentation compared to dusting (78.6% vs. 58.6%, p=0.035) at 2 months on non-contrast CT, albeit at the cost of a longer operative time (91 vs. 76 minutes, p=0.009). A 2023 systematic review and meta-analysis corroborated these findings, demonstrating that dusting was associated with a lower pooled stone-free rate (OR 0.60; 95% CI 0.41-0.89, p=0.01) and a significantly higher re-treatment rate (OR 2.03; 95% CI 1.31-3.13, p=0.001), though with a shorter operative time and comparable complication profile. These data, however, were generated predominantly with Ho:YAG laser technology and without active suction-assisted clearance, a critical limitation in extrapolating these findings to contemporary practice.
The Thulium Fiber Laser (TFL), introduced into clinical practice in 2018, represents a fundamental technological shift from the Ho:YAG platform. Operating at a wavelength of 1,940 nm, TFL demonstrates a four- to fivefold higher water absorption coefficient, a lower stone ablation threshold, and a more uniform rectangular pulse profile compared to the asymmetrical spike-decay waveform of Ho:YAG. These physical characteristics translate to superior ablation efficiency. TFL achieves fragmentation speeds up to twice and dusting speeds up to ten times faster than Ho:YAG at comparable settings, with significantly less stone retropulsion. Crucially, unlike Ho:YAG where increasing pulse energy generates larger residual fragments, TFL dusting at higher pulse energies does not increase fragment size producing dust particles consistently below 0.254 mm regardless of energy setting, making it inherently better suited to achieving fine, clearable particulate. A systematic review and meta-analysis of TFL-based RIRS reported a pooled SFR of 89.37% (95% CI: 83.93-93.12%), with TFL use independently associated with higher odds of achieving zero-fragment status in multivariable analysis.
The introduction of FANS has fundamentally altered the operative landscape of RIRS by enabling continuous active suction-assisted clearance of ablated stone material in real time. In conventional RIRS without active suction, the inferior stone-free rates historically associated with dusting were largely attributable to inadequate clearance of residual particulate from the pelvicalyceal system. With use of FANS, this limitation is addressed with fragments produced by fragmentation and dust produced by dusting both evacuated under the same negative-pressure suction system. Fragmentation with FANS requires high-energy to reduce stone burden into small fragments, followed by active suction of residual fine material. Dusting with FANS, on the other hand, converts the entire stone volume into sub-millimetre particulate that is continuously suctioned away during lasing potentially offering a more streamlined workflow with potentially less energy usage, reduced mechanical stress on the ureteroscope working channel, and fewer scope withdrawals. Given TFL's inherent superiority in generating fine, consistently small dust particles irrespective of pulse energy; the combination of TFL dusting with FANS-assisted real-time evacuation may produce stone-free outcomes equivalent or superior to fragmentation, while offering these additional operative efficiencies.
Whether dusting using TFL with FANS is non-inferior or indeed superior to fragmentation using TFL with FANS in terms of stone-free rate at one month has not been evaluated in any prospective randomised trial. This study is designed to answer that specific question in patients with renal stone less than 2cm, using a rigorously standardised equipment framework, blinded NCCT KUB-based outcome assessment, and a pre-specified non-inferiority margin of 10%.
- Conditions
- Thulium Fiber Laser, Fans, Lithotripsy, Laser, Renal Stone
- Being tested
- Dusting, Fragmentation
- Keywords
- Dusting, Fragmentation, Thulium fiber laser, FANS
- Medical subject headings
- Nephrolithiasis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DustingProcedure or surgery
Dusting employs low pulse energy (0.6-0.8 J) at higher frequency (12-15 Hz) to ablate the stone into sub-millimetre powder particles.
FragmentationProcedure or surgery
Fragmentation involves delivering high pulse energy (typically 0.6-0.8 J) at low frequency (5-10 Hz) to reduce calculi into retrievable fragments of less than 4 mm.
| Study group | Role | What they receive |
|---|---|---|
| Fragmentation | Active comparator | 0.8-1J, 5-10Hz Receives: Procedure: Fragmentation |
| Dusting | Active comparator | 0.6-0.8J, 12-15Hz Receives: Procedure: Dusting |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stone free rate
To determine whether dusting is non-inferior to fragmentation using Thulium Fiber Laser (TFL) with Flexible and Navigable Ureteral Access Sheath (FANS) with respect to stone-free rate (SFR) at 1 month post-procedure in patients with renal stones less than 2cm.
Measured: At 1 month after surgery
Secondary outcomes (9)
Operative time
To compare total operative time between fragmentation and dusting arms
Measured: Intra-operative
Lasing time
To compare laser activation time between fragmentation and dusting
Measured: Intra-operative
Energy consumption
To compare Energy consumption between two arms
Measured: Intra-operative
Ablation speed
To compare ablation speed between two arms
Measured: Intra-operative
Active suction time
To compare active suction time between fragmentation and dusting
Measured: Intra-operative
Number of scope withdrawals
To compare number of scope withdrawals during active suction between arms
Measured: Intra-operative
Re-intervention rates
To compare need of auxillary procedures to clear residual fragments between two groups
Measured: 3 months
Intra-operative Complications
To compare incidence of bleeding, PCS injury and ureteral injury between 2 groups
Measured: Intra-operatively
Post-operative complications
To compare incidence of fever, UTI, hematuria, urosepsis and ureteric stricture between two groups
Measured: at end of surgery up to 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Jun 2026
- Study start1 Aug 2026 (estimated)
- Primary completion1 Aug 2027 (estimated)
- Study completion7 Aug 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (7)Papers the sponsor has linked to this study.
- Other trials for Thulium Fiber LaserStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 86 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Bir Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Akash Chitrakar, Bir Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07639385
- Sponsor's protocol ID
- BIRH -2026-001
- Status last verified
- Jun 2026
- First submitted
- 1 Jun 2026
- Last updated
- 30 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Soto-Palou F, Chen J, Medairos R, Zhong P, Antonelli J, Preminger GM, Lipkin ME. In Pursuit of the Optimal Dusting Settings with the Thulium Fiber Laser: An In Vitro Assessment. J Endourol. 2023 Aug;37(8):914-920. doi: 10.1089/end.2023.0168. Epub 2023 Jun 26.
PubMed 37300481GBD 2021 Urolithiasis Collaborators. The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021. EClinicalMedicine. 2024 Nov 21;78:102924. doi: 10.1016/j.eclinm.2024.102924. eCollection 2024 Dec.
PubMed 39640943El-Nahas AR, Almousawi S, Alqattan Y, Alqadri IM, Al-Shaiji TF, Al-Terki A. Dusting versus fragmentation for renal stones during flexible ureteroscopy. Arab J Urol. 2019 Apr 26;17(2):138-142. doi: 10.1080/2090598X.2019.1601002. eCollection 2019.
PubMed 31285926Almasoud NA, Safar O, Elatreisy A, Alshahrani ST, Libdah SB, Alkhaldi SM, Alsoliman NF, Alderaan AM, Abdel-Al I, Abouelgreed TA, Alabeedi M, Al-Aown A. Super pulsed thulium fiber laser outcomes in retrograde intrarenal surgery for ureteral and renal stones: a systematic review and meta-analysis. BMC Urol. 2023 Nov 7;23(1):179. doi: 10.1186/s12894-023-01355-x.
PubMed 37936133Wen Z, Wang L, Liu Y, Huang J, Chen CX, Wang CJ, Chen LL, Yang XS. A systematic review and meta-analysis of outcomes between dusting and fragmentation in retrograde intrarenal surgery. BMC Urol. 2023 Jul 7;23(1):113. doi: 10.1186/s12894-023-01283-w.
PubMed 37420203Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser. World J Urol. 2020 Aug;38(8):1883-1894. doi: 10.1007/s00345-019-02654-5. Epub 2019 Feb 6.
PubMed 30729311Schoenthaler M, Wilhelm K, Kuehhas FE, Farin E, Bach C, Buchholz N, Miernik A. Postureteroscopic lesion scale: a new management modified organ injury scale--evaluation in 435 ureteroscopic patients. J Endourol. 2012 Nov;26(11):1425-30. doi: 10.1089/end.2012.0227. Epub 2012 Aug 27.
PubMed 22698147